Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Katsuaki Motoyoshi"'
Autor:
Junji Furuse, Namiki Izumi, Kenta Motomura, Yoshitaka Inaba, Yoshio Katamura, Yasuteru Kondo, Kazuhisa Yabushita, Katsuaki Motoyoshi, Masatoshi Kudo
Publikováno v:
Drugs - Real World Outcomes, Vol 10, Iss 2, Pp 195-205 (2023)
Abstract Background Lenvatinib was approved for use in unresectable hepatocellular carcinoma (uHCC) in Japan in 2018. Patients with diverse clinical characteristics receive lenvatinib treatment in clinical practice. Thus, it is crucial to evaluate th
Externí odkaz:
https://doaj.org/article/1586272cd8f54a5590c0cca0a2b18019
Autor:
Ryousuke Hara, Katsuaki Motoyoshi, Kazuhiro Kubota, Nobuyuki Fukada, Natsuko Kameyama, Ai Kojima, Hiroaki Oka, Masahito Oishi, Shigeki Igarashi, Yuko Sasaki, Shun Nakano, Shinichi Matsuda
Publikováno v:
Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku. 26:41-54
Autor:
Junji Furuse, Kenta Motomura, Yasuteru Kondo, Kazuhisa Yabushita, Namiki Izumi, Yoshitaka Inaba, Masatoshi Kudo, Katsuaki Motoyoshi, Yoshio Katamura
Publikováno v:
Journal of Clinical Oncology. 39:e16118-e16118
e16118 Background: Lenvatinib is an oral tyrosine kinase inhibitor that has been available for treatment of unresectable hepatocellular carcinoma (uHCC) in Japan since March 2018. We conducted a multicenter prospective observational study to evaluate
Autor:
Shohei Yamaguchi, Masataka Majima, Kazumasa Matsumoto, Miku Negishi, Izumi Hayashi, Masaki Nakamura, Hidero Kitasato, Katsuaki Motoyoshi, Tatsuo Saito-Taki
Publikováno v:
Inflammation and Regeneration. 31:189-195
Hematopoietic prostaglandin (PG) D synthase (H-PGDS) is known as key enzyme in the production of PGD2 and its J series metabolite, 15-deoxy-Δ12, 14-PGJ2 (15d-PGJ2), is thought to play an important role for anti-inflammatory effects. Anti-tumor effec